Treatment of multidrug-resistant tuberculosis in a remote, conflict-affected area of the Democratic Republic of Congo.
AffiliationMédecins Sans Frontières, Amsterdam, The Netherlands; Medecins
MetadataShow full item record
AbstractThe Democratic Republic of Congo is a high-burden country for multidrug-resistant tuberculosis. Médecins Sans Frontières has supported the Ministry of Health in the conflict-affected region of Shabunda since 1997. In 2006, three patients were diagnosed with drug-resistant TB (DR-TB) and had no options for further treatment. An innovative model was developed to treat these patients despite the remote setting. Key innovations were the devolving of responsibility for treatment to non-TB clinicians remotely supported by a TB specialist, use of simplified monitoring protocols, and a strong focus on addressing stigma to support adherence. Treatment was successfully completed after a median of 24 months. This pilot programme demonstrates that successful treatment for DR-TB is possible on a small scale in remote settings.
- Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.
- Authors: Rose PC, Hallbauer UM, Seddon JA, Hesseling AC, Schaaf HS
- Issue date: 2012 Dec
- Recurrence after successful treatment among patients with multidrug-resistant tuberculosis.
- Authors: Lee J, Lim HJ, Cho YJ, Park YS, Lee SM, Yang SC, Yoo CG, Kim YW, Han SK, Yim JJ
- Issue date: 2011 Oct
- Pilot study on multidrug resistant tuberculosis in Nigeria.
- Authors: Lawson L, Habib AG, Okobi MI, Idiong D, Olajide I, Emenyonu N, Onuoha N, Cuevas LE, Ogiri SO
- Issue date: 2010 Jul-Sep
- Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa.
- Authors: Cox H, Hughes J, Daniels J, Azevedo V, McDermid C, Poolman M, Boulle A, Goemaere E, van Cutsem G
- Issue date: 2014 Apr
- Mortality among tuberculosis patients in the Democratic Republic of Congo.
- Authors: Henegar C, Behets F, Vanden Driessche K, Tabala M, Bahati E, Bola V, Van Rie A
- Issue date: 2012 Sep